NCT00466661View on ClinicalTrials.gov

Acamprosate vs. Placebo in Bipolar Alcoholics

PHASE4CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Alcohol DependenceBipolar Disorder

Interventions

DRUG

Acamprosate

666 mg po TID

DRUG

Placebo

2 tabs po TID

Trial Locations (1)

29425

Institute of Psychiatry, Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Medical University of South Carolina

OTHER